UNIVERSITY COLLEGE DUBLIN (UCD)

Research Assistant, UCD School of Medicine, 12 months Full-Time

Location
Dublin
Posted
24 Jan 2022
End of advertisement period
04 Feb 2022
Ref
014075
Contact
University College Dublin
Contract Type
Temporary
Hours
Full Time

Applications are invited for a Temporary 12 month Full-Time post of a Research Assistant within the UCD School of Medicine

The HRB Irish Critical Care-Clinical Trials Network (ICC-CTN) is a methodology centre based in the UCD Clinical Research Centre at St. Vincent's University Hospital with Prof Alistair Nichol as the current Director. The ICC-CTN supports the coordination and management of critical care clinical research across Ireland and Europe in collaboration with national and global critical care colleagues. Based at the UCD Clinical Research Centre at St. Vincent's University Hospital, the ICC-CTN Research Assistant will support the REMAP-CAP study and research activities in the ICC-CTN's portfolio.

The UCD Clinical Research Centre (UCD CRC) is an academic-led, patient-focused facility for clinical translation research based at both the Mater Misericordiae and St Vincent's University Hospital. It operates under a single integrated governance structure within the UCD School of Medicine & Medical Science. In addition to supporting a large portfolio of investigator and industry-led clinical research projects, the UCD CRC is also a leader in the delivery of clinical research training.

The UCD CRC is the focal point for engagement with industry (pharmaceutical companies, CRO's, regulatory authorities) and has growing national and international collaborations. REMAP-CAP - `Randomised Embedded Multifactorial Adaptive Platform trial for Community Acquired Pneumonia' uses a study design known as a REMAP - which is a Randomised, Embedded, Multifactorial, Adaptive Platform trial.

The broad objective of this REMAP is, over time, to determine and continuously update the optimal set of treatments for community-acquired pneumonia. In a traditional clinical trial, selected patients are allocated to receive one treatment from a short list of alternatives (typically one or two). Different questions are tested sequentially. Patients who are eligible for participation in REMAP-CAP will be randomised to receive one intervention in each of one or more categories of treatment.

These interventions can be tested simultaneously. Information from patients already participating in the study can also be used to help guide the treatment of new patients joining the study. Most trials are not able to do this. The novel design of the REMAP-CAP trial enables it to adapt in the event of a pandemic to evaluate the most relevant treatment options. REMAP-CAP is evaluating new interventions and the effect of existing interventions in patients with COVID-19 pandemic infection.

Research Assistant €27,109- €28,266*

Appointment on the above range will be dependent upon qualifications and experience.

Closing date: 17:00hrs (local Irish time) on 4th February 2022

Applications must be submitted by the closing date and time specified. Any applications which are still in progress at the closing time of 17:00hrs (Local Irish Time) on the specified closing date will be cancelled automatically by the system. UCD are unable to accept late applications. UCD do not require assistance from Recruitment Agencies. Any CV's submitted by Recruitment Agencies will be returned. Prior to application, further information (including application procedure) should be obtained from the Work at UCD website: https://www.ucd.ie/workatucd/jobs/